The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Burundi learn about harm reduction from one of the pioneers on the African continent.
A new study among people entering prison in the USA suggests ‘opt-out’ testing approaches for HIV and hepatitis C virus (HCV) may need reconsideration.
Long-term survivors – those diagnosed before effective treatment for HIV was around – face unique challenges relating to their mental and physical health.
Juno Roche – writer, campaigner and woman living with HIV – shares her experiences on risk, HIV and being trans for International Transgender Day of Visibility (31 March).
PrEP, undetectable, on treatment … what does it all mean? Here we give you a quick run through in our jargon-busting blog.
New research marks welcome step to make trans women in sub-Saharan Africa visible in HIV data.
Language matters. Changing how people who use drugs are treated requires changing how we speak about them.
A US trial among 15 to 17 year-old men who have sex with men (MSM) suggests this group stands to benefit hugely should pre-exposure prophylaxis (PrEP) be approved – and supported – for this age group.
A ground-breaking review provides stark evidence of the damage criminalisation has on preventing and treating HIV among people who inject drugs.
A study of gay men in Malawi reveals very low levels of HIV testing and treatment access nationwide – with distinct geographic disparities in HIV prevalence that need to be taken into consideration and addressed.